Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Crinetics Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +8 vs. Q4 2022
- Shares held
- 55.1M
- +394.8K (+0.7%) vs. Q4 2022
- Total value
- $884.3M
- −$116.1M (−11.6%) vs. Q4 2022
- New holders
- 21
- 59 more added
- Sold out
- 13
- 28 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $4.63B |
| Q1 2026 | 244 | $4.46B |
| Q4 2025 | 242 | $5.20B |
| Q3 2025 | 225 | $4.49B |
| Q2 2025 | 222 | $3.01B |
| Q1 2025 | 227 | $3.42B |
| Q4 2024 | 247 | $5.10B |
| Q3 2024 | 235 | $4.32B |
| Q2 2024 | 234 | $3.69B |
| Q1 2024 | 203 | $3.76B |
| Q4 2023 | 181 | $2.51B |
| Q3 2023 | 172 | $2.04B |
| Q2 2023 | 140 | $974.1M |
| Q1 2023 | 129 | $884.3M |
| Q4 2022 | 122 | $1.00B |
| Q3 2022 | 122 | $1.01B |
| Q2 2022 | 111 | $944.5M |
| Q1 2022 | 116 | $997.4M |
| Q4 2021 | 118 | $1.26B |
| Q3 2021 | 94 | $708.2M |
| Q2 2021 | 83 | $616.9M |
| Q1 2021 | 80 | $465.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Crinetics Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 434,768 | $6.98M | 0.13% | +434,768 | New |
| Dimensional Fund Advisors LP | 449,605 | $7.22M | 0.00% | −59,243−11.6% | Reduced |
| Northern Trust Corp | 477,288 | $7.67M | 0.00% | −3,512−0.7% | Reduced |
| Goldman Sachs Group Inc | 520,198 | $8.35M | 0.00% | +386,882+290.2% | Added |
| GW&K Investment Management, LLC | 536,880 | $8.62M | 0.08% | +536,880 | New |
| Morgan Stanley | 652,916 | $10.5M | 0.00% | +500,328+327.9% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 691,201 | $11.1M | 0.04% | +80,511+13.2% | Added |
| Saturn V Capital Management LLC | 741,043 | $11.9M | 8.89% | +117,224+18.8% | Added |
| Opaleye Management Inc. | 785,794 | $12.6M | 3.78% | +53,794+7.3% | Added |
| 5AM Venture Management, LLC | 862,286 | $13.8M | 3.54% | 00.0% | Unchanged |
| Finepoint Capital LP | 868,427 | $13.9M | 5.33% | +45,682+5.6% | Added |
| FMR LLC | 920,958 | $14.8M | 0.00% | −962,160−51.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 929,369 | $14.9M | 0.01% | +929,369 | New |
| Geode Capital Management, LLC | 954,860 | $15.3M | 0.00% | +33,630+3.7% | Added |
| Novo Holdings A/S | 1,100,000 | $17.7M | 1.26% | +362,943+49.2% | Added |
| Paradigm Biocapital Advisors LP | 1,133,782 | $18.2M | 1.73% | +243,677+27.4% | Added |
| EcoR1 Capital, LLC | 1,330,263 | $21.4M | 0.69% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,414,823 | $22.7M | 1.65% | 00.0% | Unchanged |
| First Light Asset Management, LLC | 1,619,125 | $26.0M | 2.34% | +289,812+21.8% | Added |
| Braidwell LP | 2,019,714 | $32.4M | 1.07% | −1,449,960−41.8% | Reduced |
| State Street Corp | 2,218,794 | $35.6M | 0.00% | +214,010+10.7% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $37.0M | 4.63% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,693,062 | $43.3M | 0.00% | +306,675+12.9% | Added |
| BVF Inc | 2,736,613 | $44.0M | 1.61% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,554,887 | $57.1M | 1.69% | −484,389−12.0% | Reduced |
| Wellington Management Group LLP | 3,635,526 | $58.4M | 0.01% | +831,041+29.6% | Added |
| OrbiMed Advisors LLC | 3,950,796 | $63.4M | 1.26% | +753,920+23.6% | Added |
| BlackRock Inc. | 3,956,358 | $63.5M | 0.00% | +38,869+1.0% | Added |
| Driehaus Capital Management LLC | 5,289,519 | $84.9M | 1.19% | −335,225−6.0% | Reduced |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −1,048,829−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −152,747−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −147,000−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −66,428−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −63,100−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −31,417−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −23,338−100.0% | Sold out |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −18,600−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,222−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −744−100.0% | Sold out |
| Monarch Partners Asset Management LLC | – | – | – | – | Not filed |